Bellicum Pharmaceuticals Inc (BLCM) stock has fallen -42.60% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives BLCM stock a score of 12 out of a possible 100.
That rank is primarily influenced by a fundamental score of 8. In addition to the average rating from Wall Street analysts, BLCM stock has a mean target price of 4.5. This means analysts expect the stock to lose 21.05% over the next 12 months. BLCM's rank also includes a long-term technical score of 13. The short-term technical score for BLCM is 15.
What's Happening with BLCM Stock Today
Bellicum Pharmaceuticals Inc (BLCM) stock is down -5.79% while the S&P 500 has fallen -0.12% as of 2:55 PM on Friday, Feb 19. BLCM has fallen -$0.35 from the previous closing price of $6.05 on volume of 484,064 shares. Over the past year the S&P 500 is up 15.89% while BLCM has fallen -42.60%. BLCM lost -$11.06 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Bellicum Pharmaceuticals Inc (BLCM) Stock.
